As of now, there have been more than 10.92 million confirmed cases of the global new crown, and the number of new cases worldwide reached 340,000 on the 17th. Since the outbreak, new mutated new coronaviruses have been discovered in many countries around the world. This mutated new coronavirus has a stronger infectious power, which has made the new coronavirus epidemic in many European countries worse.
In order to deal with the deterioration of the epidemic caused by the mutation of the new coronavirus, the European Union will launch a program to study virus mutations. In this project called "HERA Incubator Program", the focus will be on identifying and analyzing virus mutations, and conducting research and development and upgrades. The next generation of new crown vaccine.
In mid-December last year, the British government announced that there was a mutation of the new coronavirus. Subsequently, the mutated virus spread more rapidly, the new crown epidemic quickly got out of control in the UK, and the number of local confirmed cases rose rapidly. At the same time, many European countries have also begun to fall in succession, and many European countries such as Denmark and the Netherlands have also successively discovered mutated new coronaviruses.
With the discovery of mutated new coronaviruses in many countries around the world, it has become more difficult to deal with this global epidemic. In addition to efforts in epidemic prevention, the research and development and production of new crown vaccines in various countries are also in full swing. The vaccination of the new crown vaccine is undoubtedly a key means to contain the epidemic, but due to the long cycle of vaccine production and development, there are only a few companies and countries that produce vaccines in the world.
At present, as many European countries have successively ordered Pfizer vaccines, the increase in orders has led to continuous delays in vaccine supply, and many European countries can only wait anxiously for the supply of vaccines. Serbia has another way of making a living and "another way of making a living", shifting its attention to Chinese vaccines. After receiving Chinese vaccines, Serbia's vaccination rate soon surpassed Germany, France and many other EU countries, becoming the highest vaccination rate among European countries One of several countries.
Facing Serbia’s "curve overtaking", some EU countries have also begun to change their attitudes and show their favor on Chinese vaccines. On the 2nd of this month, German Chancellor Angela Merkel stated that the EU welcomes every vaccine. Subsequently, the EU president also made a similar statement, which is completely different from the previous position of the Western media to maliciously discredit China's vaccines.
Under this global epidemic, the fair distribution of vaccines has become a major issue.Developed countries account for a large number of vaccine orders worldwide, while poor developing countries have difficulty obtaining vaccines. Under the battle for vaccines, many developing countries have turned their attention to China. The safety and reliability of Chinese vaccines have been recognized in clinical trials in many countries and have been widely praised by many countries.
As of now, many countries have taken the lead in approving the listing of Chinese vaccines. Nepal issued an announcement on February 17 local time to urgently approve the listing of Chinese new crown vaccines. According to reports, after Nepal has become Turkey, Brazil and other countries, Another developing country approved for vaccination against China's new crown vaccine.
Nepal, as an underdeveloped country, cannot obtain effective vaccines from other countries if it cannot obtain vaccines from China. The approval of China's vaccines this time is inseparable from the unshakable strength of China's vaccines. The achievements of the Chinese government in this new crown epidemic are also obvious to all. In the face of the unstoppable global pandemic of the new crown pneumonia epidemic, China shoulders the mission of a great power and actively responds to the call of the World Health Organization to provide 10 million doses of China's new crown vaccine to the world. The WHO's "New Coronary Pneumonia Vaccine Implementation Plan" will be used to alleviate the emergency demand for vaccines in developing countries.
China has the courage to take on the role in the most difficult time of the global epidemic, which reflects the strength and courage of my country as a big country. As early as May last year, my country announced that it would use Chinese vaccines as a global public product to provide assistance to developing countries. So far, China has provided Covid-19 vaccines to more than ten developing countries and regions around the world. In the future, China will continue to provide Covid-19 vaccine assistance to developing countries in need. China's vaccine is expected to become a global developing country in the face of global vaccine shortages. "Lifeline".
.-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-